Hims & Hers Health Inc (NYSE:HIMS) shares, rose in value on Wednesday, April 16, with the stock price down by -8.52% to the previous day’s close as strong demand from buyers drove the stock to $26.95.
Actively observing the price movement in the last trading, the stock closed the session at $29.46, falling within a range of $26.212 and $28.7198. The value of beta (5-year monthly) was 1.655 whereas the PE ratio was 50.39 over 12-month period. Referring to stock’s 52-week performance, its high was $72.98, and the low was $11.20. On the whole, HIMS has fluctuated by -14.42% over the past month.
With the market capitalization of Hims & Hers Health Inc currently standing at about $5.99 billion, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Feb-23.
Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 2.33B, with a low estimate of 529.24M and a high estimate of 551.19M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 536.45M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that HIMS’s technical picture suggests that short-term indicators denote the stock is a 50% Sell on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a Hold.
The stock’s technical analysis shows that the PEG ratio is about 1.57, with the price of HIMS currently trading nearly -10.82% and -29.33% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 41.64, while the 7-day volatility ratio is showing 7.90% which for the 30-day chart, stands at 11.18%. Furthermore, Hims & Hers Health Inc (HIMS)’s beta value is 1.85, and its average true range (ATR) is 3.61.
A comparison of Hims & Hers Health Inc (HIMS) with its peers suggests the former has fared considerably weaker in the market. HIMS showed an intraday change of -8.52% in last session, and over the past year, it grew by 103.86%%.
Data on historical trading for Hims & Hers Health Inc (NYSE:HIMS) indicates that the trading volumes over the past 10 days have averaged 22.06 and over the past 3 months, they’ve averaged 24.67 million. According to company’s latest data on outstanding shares, there are 212.46 million shares outstanding.
Nearly 18.10% of Hims & Hers Health Inc’s shares belong to company insiders and institutional investors own 73.87% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 57.77 million shares as on 2025-03-31, resulting in a short ratio of 2.53. According to the data, the short interest in Hims & Hers Health Inc (HIMS) stood at 2955.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 51.84 million. The stock has risen by 11.46% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the HIMS stock heading into the next quarter.
